美托康配合西药综合治疗冠心病心绞痛疗效观察  

Clinical observation on effect of Meituokang combined with western medicine in treating patients with angina pectoris

作　　者：杨文波[1] 李种泰[1] 孙玉琴[1] 

机构地区：[1]延边大学附属医院,吉林延吉133000

出　　处：《中成药》2008年第1期21-23,共3页Chinese Traditional Patent Medicine

摘　　要：目的:观察美托康配合西药综合治疗冠心病心绞痛的疗效。方法:选择符合诊断标准的病例共74例,随机分为对照组38例,给予西药单硝酸异山梨酯(鲁南欣康),美托洛尔,氨氯地平(络活喜,珞和喜),肠溶阿斯匹林常规治疗;治疗组36例,在西药对照组常规治疗的基础上,加用美托康注射液250 mL,每日1次,静脉滴注。两组疗程均为14 d。结果:治疗组与对照组比较,治疗组心绞痛与心电图改善总有效率为94.44%,80.56%,对照组分别为76.32%,52.63%。经统计学处理P<0.05。结论:美托康配合西药综合治疗冠心病心绞痛疗效显著。AIM： To observe the therapeutic effect of Meituokang （Floium Ginkgo Extract and Tertram Ethypyrazine injection） combined with western medicine in treating patients with angina pectoris. METHODS： 74 patients with angina pectoris were randomly divided into two groups, the control group （38 cases） were only treated with the routine Isosorbide Mononitrate; Metoprolol; Amlodipine; Aspirin enteric coated tablets and the treatment group （36 cases） were treated with Meituokang Injection qd, iv gtt besides the conventional treatment method of the control group. The course lasted 14 days. RESULTS ： In comparison, the total efficacy rate of angina pectoris and the electrocardiogram （ECG） were 94.44% and 80.56% in the treatment group and 76.32% and 52.63% in the control group, respectively. There was significant difference between two groups by statistical analysis （ P 〈 0.05 ）. CONCLUSION ： The therapeutic effect of Meituokang combined with western medicine in treating patients with angina pectoris is excellent.

关 键 词：冠心病心绞痛 美托康 西药常规治疗 

分 类 号：R287[医药卫生—中药学]